Premium
Impella ventricular assist device: A “valvular bypass” to support high‐risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement
Author(s) -
Tarantini Giuseppe,
Nai Fovino Luca
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28765
Subject(s) - impella , medicine , cardiogenic shock , cardiology , contraindication , valve replacement , aortic valve replacement , percutaneous coronary intervention , percutaneous , aortic valve , stenosis , myocardial infarction , alternative medicine , pathology
Key Points Severe aortic stenosis is usually considered a contraindication to the implantation of Impella ventricular assist device. In the setting of pre‐transcatheter aortic valve replacement (TAVR), high‐risk percutaneous coronary intervention, Impella stabilizes hemodynamics by reducing left ventricular end‐diastolic pressure and increasing cardiac output and coronary perfusion. The implantation of Impella was feasible for the treatment of cardiogenic shock occurring during TAVR. Nevertheless, 30‐day mortality remained as high as 40%.